张志将，男，博士，湖北省预防医学会心血管疾病预防与控制专业委员会委员，International Journal of Molecular Epidemiology and Genetics 杂志编委。

主要研究课题：

1.  糖尿病三级预防、糖尿病并发症控制；代谢紊乱与肿瘤

2. 心血管疾病的病因机制、生物标志物；冠心病介入治疗效果评价；

3. 全英文教学、"以问题为基础"（Problem-based learning）教学

代表性论著 ：

1.     Zhang ZJ, Bi Y, Li S, Zhang Q, Zhao G, Guo Y, Song Q. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Am J Epidemiol 2014;180(1):11-4.

2.     Zhang ZJ, Li S. The prognostic value of metformin for cancer patients with concurrent diabetes- a systematic review and meta-analysis. Diabetes Obes Metab 2014; 16(8):707-10.

3.     Zhang ZJ, Zhao G, Song Y. Attention is needed for women in the control of diabetic complications in China. Acta Diabetol. 2014 May 13. [Epub ahead of print]

4.     Zhang ZJ, Zhao G, Bi Y. Letter to the Editor: regarding "Temporal trend of mortality rate for diabetes among colorectal cancer patients from 1975 to 2009" . Ann Epidemiol 2014. [Epub ahead of print].

5.     Zhang ZJ, Zhao G, Bi Y, et al. Diabetic women suffer more years of life loss than diabetic men. International Journal of Endocrinology 2014. [Epub ahead of print]

6.     Zhang ZJ, Sun J, Xiang H, Bao M. Mortality Risk after Stent Post-dilation. Heart Lung Circ 2014; 23(8):786.

7.     Zhang ZJ. RE: "TYPE 2 DIABETES AND THE RISK OF COLORECTAL ADENOMAS: BLACK WOMEN'S HEALTH STUDY". Am J Epidemiol 2014; 179(10): 1276-7.

8.     Mei ZB, Zhang ZJ, Liu CY, Liu Y, Cui A, Liang ZL, Wang GH, Cui L.Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. PLoS One 2014;9(3):e91818.

9.     Zhang ZJ. The association between type 2 diabetes and head and neck squamous cell carcinoma. Cancer Epidemiol 2014;38(2):209.

10.    Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. The effect of stent post-dilation in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Lung Circ 2013; 22(9):787-8.

11.    Zhang ZJ. Systematic review on the association between F2-isoprostanes and cardiovascular disease. Annals of Clinical Biochemistry 2013;50(Pt 2):108-14.

12.    Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology & Metabolism 2012;97(7):2347-53.

13.    Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes-a meta-analysis. Diabetes Care 2011; 34(10):2323-8.

14.    Xu X, Nembhard WN, Kan H, Kearney G, Zhang ZJ, Talbott EO. Urinary trichlorophenol levels and increased risk of attention deficit hyperactivity disorder among US school-aged children. Occup Environ Med 2011; 68(8):557-61.

15.    Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. Glutathione S-Transferase M1 (GSTM1) and Glutathione S-Transferase T1 (GSTT1) Null Polymorphisms, Smoking, and Their Interaction in Oral Cancer: A HuGE Review and Meta-Analysis. American Journal of Epidemiology 2011; 173(8):847-57.

16.    Zhang ZJ. Mortality benefit and reduced need for repeat revascularization with statin therapy among patients undergoing percutaneous coronary intervention. Journal of Cardiology 2011; 57(3):360.

17.    Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post-dilation following stent deployment in patients presenting with and without acute myocardial infarction. American Heart Journal 2010, 160(5):979-86.

18.    Zhang ZJ, Cheng Q, Jiang GX, Marroquin OC. Statins in prevention of repeat revascularization after percutaneous coronary intervention-A meta-analysis of randomized clinical trial. Pharmacological Research 2010; 61(4):316-20.

19.    Zhang ZJ, Marroquin OC, Weissfeld JL, Stone RA, Mulukutla SR, Williams DO, Selzer F, Kip KE. Beneficial effects of statins after percutaneous coronary intervention. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(4): 445-50.

20.    张志将, 雷正龙，谢铮，尹慧，郭岩. 全球消灭脊髓灰质炎行动25周年的回顾与展望：消灭最后的千分之一. 中国全科医学, 2014, 17(27):3167-70.

21.    张志将, 李十月，燕虹，邹宇量，郭毅，向浩，陈华，毛宗福. 建构主义在流行病学教学上的应用. 中国高等医学教育, 2014, 2:16-7.

22.    张志将, 林松柏, 赵根明, 韩明. 上海市1971～2000年糖尿病引起的疾病负担趋势分析. 中华预防医学杂志 2004; 38(5): 338.

23.    张志将, 赵根明, 吴元民, 江萍. 人体测量指标和糖尿病危险状态指标的相关关系; 中国公共卫生 2002;689-690.

24.    张志将, 吴元民, 江萍，赵根明. 社区自然人群中糖尿病慢性并发症危险因素的探索研究. 中国全科医学 2001; 4(12)：970-972.